266 related articles for article (PubMed ID: 35992916)
1. The value of 3D pseudo-continuousarterial spin labeling perfusion imaging in moyamoya disease-Comparison with dynamic susceptibility contrast perfusion imaging.
Zhang H; Lu M; Liu S; Liu D; Shen X; Sheng F; Han C; Cai J
Front Neurosci; 2022; 16():944246. PubMed ID: 35992916
[TBL] [Abstract][Full Text] [Related]
2. Clinical assessment of cerebral hemodynamics in Moyamoya disease via multiple inversion time arterial spin labeling and dynamic susceptibility contrast-magnetic resonance imaging: A comparative study.
Qiao PG; Han C; Zuo ZW; Wang YT; Pfeuffer J; Duan L; Qian T; Li GJ
J Neuroradiol; 2017 Jul; 44(4):273-280. PubMed ID: 28168990
[TBL] [Abstract][Full Text] [Related]
3. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI.
Wong AM; Yan FX; Liu HL
J Magn Reson Imaging; 2014 Feb; 39(2):427-33. PubMed ID: 23677620
[TBL] [Abstract][Full Text] [Related]
5. [Multi-parameter arterial spin labeling versus dynamic magnetic-sensitive enhanced cerebral perfusion imaging for diagnosis of transient cerebral ischemic attack].
Xu Y; Lv JH; Ma L; Chen WJ; Lou X
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):768-74. PubMed ID: 27320876
[TBL] [Abstract][Full Text] [Related]
6. Comparison of arterial spin labeling perfusion with dynamic susceptibility contrast perfusion in Moyamoya disease.
Yadav N; Pendharkar H; Gupta AK; Prasad C; Shukla D; Kandavel T; Bansal S
J Neurosci Rural Pract; 2023; 14(2):286-292. PubMed ID: 37181159
[TBL] [Abstract][Full Text] [Related]
7. Multi-delay arterial spin labeling perfusion MRI in moyamoya disease--comparison with CT perfusion imaging.
Wang R; Yu S; Alger JR; Zuo Z; Chen J; Wang R; An J; Wang B; Zhao J; Xue R; Wang DJ
Eur Radiol; 2014 May; 24(5):1135-44. PubMed ID: 24557051
[TBL] [Abstract][Full Text] [Related]
8. Arterial spin-labeling cerebral perfusion changes after revascularization surgery in pediatric moyamoya disease and syndrome.
Quon JL; Kim LH; Lober RM; Maleki M; Steinberg GK; Yeom KW
J Neurosurg Pediatr; 2019 Feb; 23(4):486-492. PubMed ID: 30738390
[TBL] [Abstract][Full Text] [Related]
9. Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke - Comparison with dynamic susceptibility contrast enhanced perfusion imaging.
Wang DJ; Alger JR; Qiao JX; Gunther M; Pope WB; Saver JL; Salamon N; Liebeskind DS;
Neuroimage Clin; 2013; 3():1-7. PubMed ID: 24159561
[TBL] [Abstract][Full Text] [Related]
10. A perfusion territory shift attributable solely to the secondary collaterals in moyamoya patients: a potential risk factor for preoperative hemorrhagic stroke revealed by t-ASL and 3D-TOF-MRA.
Gao XY; Li Q; Li JR; Zhou Q; Qu JX; Yao ZW
J Neurosurg; 2019 Aug; 133(3):780-788. PubMed ID: 31398708
[TBL] [Abstract][Full Text] [Related]
11. Multi-phase 3D arterial spin labeling brain MRI in assessing cerebral blood perfusion and arterial transit times in children at 3T.
Hu HH; Rusin JA; Peng R; Shao X; Smith M; Krishnamurthy R; Selvaraj B; Wang DJJ
Clin Imaging; 2019; 53():210-220. PubMed ID: 30439588
[TBL] [Abstract][Full Text] [Related]
12. Spatial coefficient of variation applied to arterial spin labeling MRI may contribute to predict surgical revascularization outcomes in pediatric moyamoya vasculopathy.
Tortora D; Scavetta C; Rebella G; Bertamino M; Scala M; Giacomini T; Morana G; Pavanello M; Rossi A; Severino M
Neuroradiology; 2020 Aug; 62(8):1003-1015. PubMed ID: 32415392
[TBL] [Abstract][Full Text] [Related]
13. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
[TBL] [Abstract][Full Text] [Related]
14. Three-Dimensional Arterial Spin Labeling for the Evaluation of the Cerebral Hemodynamics in Ischemic and Hemorrhagic Moyamoya Disease.
Bian H; Zhang L; Wang J
Cerebrovasc Dis; 2024; 53(3):307-315. PubMed ID: 37722371
[TBL] [Abstract][Full Text] [Related]
15. Can combined high-resolution vessel wall imaging and multiple post-labeling delay 3D pseudo-continuous arterial spin labeling differentiate moyamoya disease from atherosclerotic moyamoya syndrome?
Guo Y; Dou W; Wang X; Wang X; Mao H; Chen K
Eur J Radiol; 2023 Dec; 169():111184. PubMed ID: 37931375
[TBL] [Abstract][Full Text] [Related]
16. Non-contrast hemodynamic imaging of Moyamoya disease with MR fingerprinting ASL: A feasibility study.
Su P; Liu P; Pinho MC; Thomas BP; Qiao Y; Huang J; Welch BG; Lu H
Magn Reson Imaging; 2022 May; 88():116-122. PubMed ID: 35183659
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of MR mTI-ASL and DSC-PWI in evaluating cerebral hemodynamics of patients with Moyamoya disease.
Zhang J; Xia C; Liu Y; Qian W; Peng W; Liu K; Li L; Zhao F; Li Z
Medicine (Baltimore); 2018 Oct; 97(41):e12768. PubMed ID: 30313089
[TBL] [Abstract][Full Text] [Related]
18. Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI.
Goetti R; O'Gorman R; Khan N; Kellenberger CJ; Scheer I
Neuroradiology; 2013 May; 55(5):639-47. PubMed ID: 23404242
[TBL] [Abstract][Full Text] [Related]
19. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.
Qu Y; Kong D; Wen H; Ou X; Rui Q; Wang X; Lin DD; Qin Q; Wen Z
Eur Radiol; 2022 May; 32(5):2976-2987. PubMed ID: 35066634
[TBL] [Abstract][Full Text] [Related]
20. Perfusion magnetic resonance imaging provides additional information as compared to anatomical imaging for decision-making in vestibular schwannoma.
Kleijwegt MC; van der Mey AG; Wiggers-deBruine FT; Malessy MJ; van Osch MJ
Eur J Radiol Open; 2016; 3():127-33. PubMed ID: 27366777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
